Analysts Set agilon health, inc. (NYSE:AGL) PT at $4.03

agilon health, inc. (NYSE:AGL - Get Free Report) has received a consensus recommendation of "Hold" from the eighteen ratings firms that are currently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, fourteen have issued a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $4.03.

A number of analysts have recently weighed in on the stock. Evercore ISI cut their price target on shares of agilon health from $7.00 to $4.00 and set an "in-line" rating for the company in a report on Tuesday, October 8th. JMP Securities lowered agilon health from an "outperform" rating to a "market perform" rating in a research note on Monday, November 11th. Sanford C. Bernstein upped their price objective on agilon health from $2.50 to $3.15 and gave the stock a "market perform" rating in a research report on Wednesday. Bank of America cut agilon health from a "buy" rating to an "underperform" rating and set a $3.00 target price on the stock. in a research report on Wednesday, October 2nd. Finally, William Blair downgraded shares of agilon health from an "outperform" rating to a "market perform" rating in a research note on Friday, November 8th.

Insider Buying and Selling at agilon health

In other news, Director John William Wulf purchased 45,000 shares of the business's stock in a transaction that occurred on Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the acquisition, the director now owns 206,133 shares in the company, valued at $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Karen Mcloughlin acquired 25,000 shares of the firm's stock in a transaction on Friday, December 13th. The stock was purchased at an average price of $2.20 per share, with a total value of $55,000.00. Following the purchase, the director now owns 73,166 shares in the company, valued at approximately $160,965.20. The trade was a 51.90 % increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 90,000 shares of company stock valued at $198,100. Corporate insiders own 3.20% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of AGL. AQR Capital Management LLC raised its holdings in shares of agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company's stock worth $8,871,000 after purchasing an additional 1,316,990 shares during the period. JPMorgan Chase & Co. raised its stake in shares of agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock valued at $5,563,000 after buying an additional 1,083,492 shares during the period. Susquehanna Fundamental Investments LLC raised its stake in shares of agilon health by 65.0% in the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company's stock valued at $5,262,000 after buying an additional 316,856 shares during the period. Citigroup Inc. lifted its position in shares of agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock valued at $7,971,000 after buying an additional 1,941,993 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of agilon health during the 2nd quarter worth $1,849,000.

agilon health Stock Performance

Shares of AGL traded up $0.16 during mid-day trading on Friday, hitting $3.12. 7,729,587 shares of the company's stock were exchanged, compared to its average volume of 2,641,922. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 52 week low of $1.50 and a 52 week high of $7.73. The stock's 50-day simple moving average is $2.10 and its 200-day simple moving average is $3.63.

agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same period in the prior year, the firm earned ($0.06) earnings per share. Research analysts predict that agilon health will post -0.59 earnings per share for the current year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.